This report is a review of the clinical uses, impacts on clinical management, clinical outcome and resource use of Positron Emission Tomography (PET) at Royal Prince Alfred Hospital (RPAH).Positron emission tomography

Anastasia Lowin

Christine Pollicino

Michael Fulham

Phil Haywood

Rosalie viney

English

Research Papers in Economics

A Delphi study to establish national cost-effectiveness research priorities for positron emission tomography.

Analytical decision model for the costeffective management of solitary pulmonary nodules.

Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET. Radiology

Comparison of cost-effectiveness and utility of exercise ECG, single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease. [see comments].

Cost-effectiveness analysis of therapy for symptomatic carotid occlusion: PET screening before selective extracranial-tointracranial bypass versus medical treatment.

Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease.

Cost-effectiveness of FDG-PET for staging nonsmall cell lung cancer: a decision analysis.

Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results.

Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany.

Cost-effectiveness of PET imaging in clinical oncology.

Decision tree sensitivity analysis for costeffectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma [see comments].

Decision-tree sensitivity analysis for costeffectiveness of chest 2-fluoro-2-D-[(18)F]fluorodeoxyglucose positron emission tomography in patients with pulmonary nodules (non-small cell lung carcinoma) in Japan.

Detection of extrathoracic metastases by positron emission tomography in lung cancer.

Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer.

Evaluation of the role of positron emission tomography in oncology.

of Health and Aged Care

Outcomes and costs of positron emission tomography: comparison of intravenous adenosine and intravenous dipyridamole.

Positron emission tomography : descriptive analysis of experience

Positron emission tomography (PET): experience with a large-field-of-view hree-dimensional PET scanner.

Primary staging of lymphomas: cost-effectiveness of FDG-PET versus computed tomography.

Prospective investigation of positron emission tomography in lung nodules.

Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology

Usefulness of positron emission tomography imaging in the management of lung cancer.

Whole body FDG PET imaging for the staging of malignant melanoma: is it cost-effective?

Review of Positron Emission Tomography at Royal Prince Alfred Hospital, CHERE Project Report No 18

Review of Positron Emission Tomography at Royal Prince Alfred Hospital, CHERE Project Report No 18

Abstract

Similar works

Full text

Available Versions

Research Papers in Economics